APO RESEARCH · REPORT
Rosuvastatin Calcium
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
Product & engineering
Understand the product.
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.
Selected research
Industry Research
Rosuvastatin Calcium Industry Research Report 2026
Market perspective
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.
In additional, EU is also the largest consumer of rosuvastatin calcium, about 34% of the global production was consumed in EU. China is the second producer with the market share of 28%. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55% of the total amount.
Read the full market overview
Report Scope
This report quantifies the global Rosuvastatin Calcium market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Rosuvastatin Calcium Market by Company
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences
Rosuvastatin Calcium Segment by Type
Purity 98.0%
Purity 99.0%
Other
Rosuvastatin Calcium Segment by Application
Tablet (including dispersible tablet and general tablet)
Capsule
Others
Rosuvastatin Calcium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosuvastatin Calcium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rosuvastatin Calcium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosuvastatin Calcium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Rosuvastatin Calcium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Rosuvastatin Calcium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Rosuvastatin Calcium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 98.0%
- Purity 99.0%
- Other
Applications
- Tablet (including dispersible tablet and general tablet)
- Capsule
- Others
Companies covered
- AstraZeneca
- Teva Pharmaceutical Industries
- MSN Laboratories
- Cadila Pharmaceuticals
- LGM Pharma
- Bal Pharma
- Changzhou Pharmaceutical Factory
- Jingxin Pharm
- Zhejiang Hisun Pharmaceutical
- HEC Pharm
- Lunan Pharmaceutical
- Nanjing Frochem Tech
- Lianyungang Runzhong Pharmaceutical
- Shandong Bechem Chemicals
- CTX Life Sciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Rosuvastatin Calcium Market Size (2021-2032)
- 2.2.2 Global Rosuvastatin Calcium Sales (2021-2032)
- 2.2.3 Global Rosuvastatin Calcium Market Average Price (2021-2032)
- 2.3 Rosuvastatin Calcium by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity 98.0%
- 2.3.3 Purity 99.0%
- 2.3.4 Other
- 2.4 Rosuvastatin Calcium by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Tablet (including dispersible tablet and general tablet)
- 2.4.3 Capsule
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Rosuvastatin Calcium Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Rosuvastatin Calcium Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Rosuvastatin Calcium Revenue of Manufacturers (2021-2026)
- 3.4 Global Rosuvastatin Calcium Average Price by Manufacturers (2021-2026)
- 3.5 Global Rosuvastatin Calcium Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Rosuvastatin Calcium, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Rosuvastatin Calcium, Product Type & Application
- 3.8 Global Manufacturers of Rosuvastatin Calcium, Established Date
- 3.9 Global Rosuvastatin Calcium Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AstraZeneca
- 4.1.1 AstraZeneca Company Information
- 4.1.2 AstraZeneca Business Overview
- 4.1.3 AstraZeneca Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AstraZeneca Rosuvastatin Calcium Product Portfolio
- 4.1.5 AstraZeneca Recent Developments
- 4.2 Teva Pharmaceutical Industries
- 4.2.1 Teva Pharmaceutical Industries Company Information
- 4.2.2 Teva Pharmaceutical Industries Business Overview
- 4.2.3 Teva Pharmaceutical Industries Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Teva Pharmaceutical Industries Rosuvastatin Calcium Product Portfolio
- 4.2.5 Teva Pharmaceutical Industries Recent Developments
- 4.3 MSN Laboratories
- 4.3.1 MSN Laboratories Company Information
- 4.3.2 MSN Laboratories Business Overview
- 4.3.3 MSN Laboratories Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 MSN Laboratories Rosuvastatin Calcium Product Portfolio
- 4.3.5 MSN Laboratories Recent Developments
- 4.4 Cadila Pharmaceuticals
- 4.4.1 Cadila Pharmaceuticals Company Information
- 4.4.2 Cadila Pharmaceuticals Business Overview
- 4.4.3 Cadila Pharmaceuticals Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cadila Pharmaceuticals Rosuvastatin Calcium Product Portfolio
- 4.4.5 Cadila Pharmaceuticals Recent Developments
- 4.5 LGM Pharma
- 4.5.1 LGM Pharma Company Information
- 4.5.2 LGM Pharma Business Overview
- 4.5.3 LGM Pharma Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 LGM Pharma Rosuvastatin Calcium Product Portfolio
- 4.5.5 LGM Pharma Recent Developments
- 4.6 Bal Pharma
- 4.6.1 Bal Pharma Company Information
- 4.6.2 Bal Pharma Business Overview
- 4.6.3 Bal Pharma Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bal Pharma Rosuvastatin Calcium Product Portfolio
- 4.6.5 Bal Pharma Recent Developments
- 4.7 Changzhou Pharmaceutical Factory
- 4.7.1 Changzhou Pharmaceutical Factory Company Information
- 4.7.2 Changzhou Pharmaceutical Factory Business Overview
- 4.7.3 Changzhou Pharmaceutical Factory Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Changzhou Pharmaceutical Factory Rosuvastatin Calcium Product Portfolio
- 4.7.5 Changzhou Pharmaceutical Factory Recent Developments
- 4.8 Jingxin Pharm
- 4.8.1 Jingxin Pharm Company Information
- 4.8.2 Jingxin Pharm Business Overview
- 4.8.3 Jingxin Pharm Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jingxin Pharm Rosuvastatin Calcium Product Portfolio
- 4.8.5 Jingxin Pharm Recent Developments
- 4.9 Zhejiang Hisun Pharmaceutical
- 4.9.1 Zhejiang Hisun Pharmaceutical Company Information
- 4.9.2 Zhejiang Hisun Pharmaceutical Business Overview
- 4.9.3 Zhejiang Hisun Pharmaceutical Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Zhejiang Hisun Pharmaceutical Rosuvastatin Calcium Product Portfolio
- 4.9.5 Zhejiang Hisun Pharmaceutical Recent Developments
- 4.10 HEC Pharm
- 4.10.1 HEC Pharm Company Information
- 4.10.2 HEC Pharm Business Overview
- 4.10.3 HEC Pharm Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 HEC Pharm Rosuvastatin Calcium Product Portfolio
- 4.10.5 HEC Pharm Recent Developments
- 4.11 Lunan Pharmaceutical
- 4.11.1 Lunan Pharmaceutical Company Information
- 4.11.2 Lunan Pharmaceutical Business Overview
- 4.11.3 Lunan Pharmaceutical Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Lunan Pharmaceutical Rosuvastatin Calcium Product Portfolio
- 4.11.5 Lunan Pharmaceutical Recent Developments
- 4.12 Nanjing Frochem Tech
- 4.12.1 Nanjing Frochem Tech Company Information
- 4.12.2 Nanjing Frochem Tech Business Overview
- 4.12.3 Nanjing Frochem Tech Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Nanjing Frochem Tech Rosuvastatin Calcium Product Portfolio
- 4.12.5 Nanjing Frochem Tech Recent Developments
- 4.13 Lianyungang Runzhong Pharmaceutical
- 4.13.1 Lianyungang Runzhong Pharmaceutical Company Information
- 4.13.2 Lianyungang Runzhong Pharmaceutical Business Overview
- 4.13.3 Lianyungang Runzhong Pharmaceutical Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Lianyungang Runzhong Pharmaceutical Rosuvastatin Calcium Product Portfolio
- 4.13.5 Lianyungang Runzhong Pharmaceutical Recent Developments
- 4.14 Shandong Bechem Chemicals
- 4.14.1 Shandong Bechem Chemicals Company Information
- 4.14.2 Shandong Bechem Chemicals Business Overview
- 4.14.3 Shandong Bechem Chemicals Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Shandong Bechem Chemicals Rosuvastatin Calcium Product Portfolio
- 4.14.5 Shandong Bechem Chemicals Recent Developments
- 4.15 CTX Life Sciences
- 4.15.1 CTX Life Sciences Company Information
- 4.15.2 CTX Life Sciences Business Overview
- 4.15.3 CTX Life Sciences Rosuvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 CTX Life Sciences Rosuvastatin Calcium Product Portfolio
- 4.15.5 CTX Life Sciences Recent Developments
5 Global Rosuvastatin Calcium Market Scenario by Region
- 5.1 Global Rosuvastatin Calcium Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Rosuvastatin Calcium Sales by Region: 2021-2032
- 5.2.1 Global Rosuvastatin Calcium Sales by Region: 2021-2026
- 5.2.2 Global Rosuvastatin Calcium Sales by Region: 2027-2032
- 5.3 Global Rosuvastatin Calcium Revenue by Region: 2021-2032
- 5.3.1 Global Rosuvastatin Calcium Revenue by Region: 2021-2026
- 5.3.2 Global Rosuvastatin Calcium Revenue by Region: 2027-2032
- 5.4 North America Rosuvastatin Calcium Market Facts & Figures by Country
- 5.4.1 North America Rosuvastatin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Rosuvastatin Calcium Sales by Country (2021-2032)
- 5.4.3 North America Rosuvastatin Calcium Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Rosuvastatin Calcium Market Facts & Figures by Country
- 5.5.1 Europe Rosuvastatin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Rosuvastatin Calcium Sales by Country (2021-2032)
- 5.5.3 Europe Rosuvastatin Calcium Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Rosuvastatin Calcium Market Facts & Figures by Country
- 5.6.1 Asia Pacific Rosuvastatin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Rosuvastatin Calcium Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Rosuvastatin Calcium Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Rosuvastatin Calcium Market Facts & Figures by Country
- 5.7.1 South America Rosuvastatin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Rosuvastatin Calcium Sales by Country (2021-2032)
- 5.7.3 South America Rosuvastatin Calcium Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Rosuvastatin Calcium Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Rosuvastatin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Rosuvastatin Calcium Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Rosuvastatin Calcium Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Rosuvastatin Calcium Sales by Type (2021-2032)
- 6.1.1 Global Rosuvastatin Calcium Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Rosuvastatin Calcium Sales Market Share by Type (2021-2032)
- 6.2 Global Rosuvastatin Calcium Revenue by Type (2021-2032)
- 6.2.1 Global Rosuvastatin Calcium Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Rosuvastatin Calcium Revenue Market Share by Type (2021-2032)
- 6.3 Global Rosuvastatin Calcium Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Rosuvastatin Calcium Sales by Application (2021-2032)
- 7.1.1 Global Rosuvastatin Calcium Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Rosuvastatin Calcium Sales Market Share by Application (2021-2032)
- 7.2 Global Rosuvastatin Calcium Revenue by Application (2021-2032)
- 7.2.1 Global Rosuvastatin Calcium Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Rosuvastatin Calcium Revenue Market Share by Application (2021-2032)
- 7.3 Global Rosuvastatin Calcium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Rosuvastatin Calcium Value Chain Analysis
- 8.1.1 Rosuvastatin Calcium Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Rosuvastatin Calcium Production Mode & Process
- 8.2 Rosuvastatin Calcium Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Rosuvastatin Calcium Distributors
- 8.2.3 Rosuvastatin Calcium Customers
9 Global Rosuvastatin Calcium Analyzing Market Dynamics
- 9.1 Rosuvastatin Calcium Industry Trends
- 9.2 Rosuvastatin Calcium Industry Drivers
- 9.3 Rosuvastatin Calcium Industry Opportunities and Challenges
- 9.4 Rosuvastatin Calcium Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst